PGEN
PRECIGEN, INC.
NASDAQ · Healthcare · Biotechnology · US
$6.66
+4.31%Forward multiples
Based on analyst estimates
- P/E forward
- 9.68x
- P/E 2026E
- 38.66x
- P/E 2027E
- 10.42x
- P/E 2028E
- 9.46x
- P/S forward
- 6.90x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 54.72x
- Price / sales
- 27.82x
- Price / cash flow
- -20.89x
Enterprise value
- Enterprise value
- $2.4B
- EV / sales
- 28.52x
- EV / EBITDA
- -17.00x
- EV / EBIT
- -61.89x
- Market cap
- $2.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026